nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—PGD—Methotrexate—bone cancer	0.321	0.389	CbGbCtD
Furosemide—SLC22A11—Methotrexate—bone cancer	0.0952	0.115	CbGbCtD
Furosemide—ABCC2—Carboplatin—bone cancer	0.0951	0.115	CbGbCtD
Furosemide—ABCC2—Cisplatin—bone cancer	0.0812	0.0982	CbGbCtD
Furosemide—SLC22A8—Methotrexate—bone cancer	0.0554	0.067	CbGbCtD
Furosemide—ABCC2—Doxorubicin—bone cancer	0.0544	0.0658	CbGbCtD
Furosemide—ABCC2—Methotrexate—bone cancer	0.0527	0.0638	CbGbCtD
Furosemide—SLC22A6—Methotrexate—bone cancer	0.0386	0.0467	CbGbCtD
Furosemide—ALB—Methotrexate—bone cancer	0.0329	0.0397	CbGbCtD
Furosemide—Indapamide—CYP3A4—bone cancer	0.00193	0.538	CrCbGaD
Furosemide—Bumetanide—PTGS2—bone cancer	0.00166	0.462	CrCbGaD
Furosemide—Erythema—Cisplatin—bone cancer	0.000558	0.00329	CcSEcCtD
Furosemide—Malnutrition—Cisplatin—bone cancer	0.000558	0.00329	CcSEcCtD
Furosemide—Cramps of lower extremities—Doxorubicin—bone cancer	0.000557	0.00329	CcSEcCtD
Furosemide—Flatulence—Cisplatin—bone cancer	0.00055	0.00324	CcSEcCtD
Furosemide—Thrombophlebitis—Epirubicin—bone cancer	0.00055	0.00324	CcSEcCtD
Furosemide—Bladder pain—Doxorubicin—bone cancer	0.000548	0.00323	CcSEcCtD
Furosemide—Diabetes mellitus—Epirubicin—bone cancer	0.000547	0.00323	CcSEcCtD
Furosemide—Photosensitivity—Epirubicin—bone cancer	0.000542	0.0032	CcSEcCtD
Furosemide—Dermatitis exfoliative—Methotrexate—bone cancer	0.000539	0.00318	CcSEcCtD
Furosemide—Muscle spasms—Cisplatin—bone cancer	0.000537	0.00316	CcSEcCtD
Furosemide—Vascular purpura—Epirubicin—bone cancer	0.000532	0.00314	CcSEcCtD
Furosemide—Mental disability—Doxorubicin—bone cancer	0.000526	0.0031	CcSEcCtD
Furosemide—Vision blurred—Cisplatin—bone cancer	0.000526	0.0031	CcSEcCtD
Furosemide—Anaphylactoid reaction—Methotrexate—bone cancer	0.000525	0.0031	CcSEcCtD
Furosemide—Lethargy—Methotrexate—bone cancer	0.000519	0.00306	CcSEcCtD
Furosemide—Anaemia—Cisplatin—bone cancer	0.000516	0.00304	CcSEcCtD
Furosemide—Thrombophlebitis—Doxorubicin—bone cancer	0.000509	0.003	CcSEcCtD
Furosemide—Diabetes mellitus—Doxorubicin—bone cancer	0.000506	0.00298	CcSEcCtD
Furosemide—Dermatitis exfoliative—Epirubicin—bone cancer	0.000504	0.00297	CcSEcCtD
Furosemide—Photosensitivity—Doxorubicin—bone cancer	0.000501	0.00296	CcSEcCtD
Furosemide—Leukopenia—Cisplatin—bone cancer	0.0005	0.00295	CcSEcCtD
Furosemide—Dermatitis bullous—Epirubicin—bone cancer	0.000498	0.00294	CcSEcCtD
Furosemide—Purpura—Epirubicin—bone cancer	0.000494	0.00291	CcSEcCtD
Furosemide—Vascular purpura—Doxorubicin—bone cancer	0.000492	0.0029	CcSEcCtD
Furosemide—Anaphylactoid reaction—Epirubicin—bone cancer	0.000492	0.0029	CcSEcCtD
Furosemide—Lethargy—Epirubicin—bone cancer	0.000486	0.00286	CcSEcCtD
Furosemide—Irritability—Methotrexate—bone cancer	0.000485	0.00286	CcSEcCtD
Furosemide—Hyponatraemia—Epirubicin—bone cancer	0.000478	0.00282	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000472	0.00278	CcSEcCtD
Furosemide—Dermatitis exfoliative—Doxorubicin—bone cancer	0.000467	0.00275	CcSEcCtD
Furosemide—Dermatitis bullous—Doxorubicin—bone cancer	0.000461	0.00272	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.000458	0.0027	CcSEcCtD
Furosemide—Purpura—Doxorubicin—bone cancer	0.000457	0.00269	CcSEcCtD
Furosemide—Anaphylactic shock—Cisplatin—bone cancer	0.000455	0.00269	CcSEcCtD
Furosemide—Anaphylactoid reaction—Doxorubicin—bone cancer	0.000455	0.00268	CcSEcCtD
Furosemide—Lethargy—Doxorubicin—bone cancer	0.000449	0.00265	CcSEcCtD
Furosemide—Nervous system disorder—Cisplatin—bone cancer	0.000447	0.00263	CcSEcCtD
Furosemide—Thrombocytopenia—Cisplatin—bone cancer	0.000446	0.00263	CcSEcCtD
Furosemide—Blood creatinine increased—Epirubicin—bone cancer	0.000446	0.00263	CcSEcCtD
Furosemide—Dehydration—Epirubicin—bone cancer	0.000443	0.00261	CcSEcCtD
Furosemide—Skin disorder—Cisplatin—bone cancer	0.000442	0.00261	CcSEcCtD
Furosemide—Hyponatraemia—Doxorubicin—bone cancer	0.000442	0.00261	CcSEcCtD
Furosemide—Hyperhidrosis—Cisplatin—bone cancer	0.00044	0.0026	CcSEcCtD
Furosemide—Eosinophilia—Methotrexate—bone cancer	0.000435	0.00257	CcSEcCtD
Furosemide—Orthostatic hypotension—Epirubicin—bone cancer	0.000435	0.00256	CcSEcCtD
Furosemide—Anorexia—Cisplatin—bone cancer	0.000434	0.00256	CcSEcCtD
Furosemide—Hypokalaemia—Epirubicin—bone cancer	0.000433	0.00255	CcSEcCtD
Furosemide—Pancreatitis—Methotrexate—bone cancer	0.000431	0.00254	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.000429	0.00253	CcSEcCtD
Furosemide—Hypotension—Cisplatin—bone cancer	0.000426	0.00251	CcSEcCtD
Furosemide—Muscular weakness—Epirubicin—bone cancer	0.00042	0.00247	CcSEcCtD
Furosemide—Abdominal distension—Epirubicin—bone cancer	0.000414	0.00244	CcSEcCtD
Furosemide—Blood creatinine increased—Doxorubicin—bone cancer	0.000413	0.00243	CcSEcCtD
Furosemide—Dehydration—Doxorubicin—bone cancer	0.00041	0.00241	CcSEcCtD
Furosemide—Paraesthesia—Cisplatin—bone cancer	0.000409	0.00241	CcSEcCtD
Furosemide—Eosinophilia—Epirubicin—bone cancer	0.000407	0.0024	CcSEcCtD
Furosemide—Pancreatitis—Epirubicin—bone cancer	0.000403	0.00238	CcSEcCtD
Furosemide—Orthostatic hypotension—Doxorubicin—bone cancer	0.000402	0.00237	CcSEcCtD
Furosemide—Photosensitivity reaction—Methotrexate—bone cancer	0.000401	0.00237	CcSEcCtD
Furosemide—Hypokalaemia—Doxorubicin—bone cancer	0.000401	0.00236	CcSEcCtD
Furosemide—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.000397	0.00234	CcSEcCtD
Furosemide—Decreased appetite—Cisplatin—bone cancer	0.000396	0.00233	CcSEcCtD
Furosemide—Gastrointestinal disorder—Cisplatin—bone cancer	0.000393	0.00232	CcSEcCtD
Furosemide—Drowsiness—Methotrexate—bone cancer	0.000392	0.00231	CcSEcCtD
Furosemide—Pain—Cisplatin—bone cancer	0.000389	0.0023	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000389	0.00229	CcSEcCtD
Furosemide—Muscular weakness—Doxorubicin—bone cancer	0.000388	0.00229	CcSEcCtD
Furosemide—Renal failure—Methotrexate—bone cancer	0.000385	0.00227	CcSEcCtD
Furosemide—Abdominal distension—Doxorubicin—bone cancer	0.000383	0.00226	CcSEcCtD
Furosemide—Pollakiuria—Epirubicin—bone cancer	0.00038	0.00224	CcSEcCtD
Furosemide—Eosinophilia—Doxorubicin—bone cancer	0.000377	0.00222	CcSEcCtD
Furosemide—Sweating—Methotrexate—bone cancer	0.000376	0.00222	CcSEcCtD
Furosemide—Photosensitivity reaction—Epirubicin—bone cancer	0.000375	0.00221	CcSEcCtD
Furosemide—Feeling abnormal—Cisplatin—bone cancer	0.000375	0.00221	CcSEcCtD
Furosemide—Pancreatitis—Doxorubicin—bone cancer	0.000373	0.0022	CcSEcCtD
Furosemide—Hyperglycaemia—Epirubicin—bone cancer	0.000371	0.00219	CcSEcCtD
Furosemide—Hepatobiliary disease—Methotrexate—bone cancer	0.000371	0.00219	CcSEcCtD
Furosemide—Drowsiness—Epirubicin—bone cancer	0.000367	0.00216	CcSEcCtD
Furosemide—Agranulocytosis—Methotrexate—bone cancer	0.000366	0.00216	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000364	0.00214	CcSEcCtD
Furosemide—Renal failure—Epirubicin—bone cancer	0.000361	0.00213	CcSEcCtD
Furosemide—Body temperature increased—Cisplatin—bone cancer	0.00036	0.00212	CcSEcCtD
Furosemide—Sweating—Epirubicin—bone cancer	0.000352	0.00207	CcSEcCtD
Furosemide—Pollakiuria—Doxorubicin—bone cancer	0.000352	0.00207	CcSEcCtD
Furosemide—Urinary tract disorder—Methotrexate—bone cancer	0.000347	0.00205	CcSEcCtD
Furosemide—Photosensitivity reaction—Doxorubicin—bone cancer	0.000347	0.00205	CcSEcCtD
Furosemide—Hepatobiliary disease—Epirubicin—bone cancer	0.000347	0.00204	CcSEcCtD
Furosemide—Urethral disorder—Methotrexate—bone cancer	0.000345	0.00203	CcSEcCtD
Furosemide—Hyperglycaemia—Doxorubicin—bone cancer	0.000343	0.00202	CcSEcCtD
Furosemide—Agranulocytosis—Epirubicin—bone cancer	0.000342	0.00202	CcSEcCtD
Furosemide—Drowsiness—Doxorubicin—bone cancer	0.000339	0.002	CcSEcCtD
Furosemide—Visual impairment—Methotrexate—bone cancer	0.000339	0.002	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.000336	0.00198	CcSEcCtD
Furosemide—Hypersensitivity—Cisplatin—bone cancer	0.000336	0.00198	CcSEcCtD
Furosemide—Renal failure—Doxorubicin—bone cancer	0.000334	0.00197	CcSEcCtD
Furosemide—Erythema multiforme—Methotrexate—bone cancer	0.000333	0.00196	CcSEcCtD
Furosemide—Eye disorder—Methotrexate—bone cancer	0.000329	0.00194	CcSEcCtD
Furosemide—Tinnitus—Methotrexate—bone cancer	0.000328	0.00193	CcSEcCtD
Furosemide—Asthenia—Cisplatin—bone cancer	0.000327	0.00193	CcSEcCtD
Furosemide—Sweating—Doxorubicin—bone cancer	0.000325	0.00192	CcSEcCtD
Furosemide—Urinary tract disorder—Epirubicin—bone cancer	0.000325	0.00192	CcSEcCtD
Furosemide—Urethral disorder—Epirubicin—bone cancer	0.000323	0.0019	CcSEcCtD
Furosemide—Hepatobiliary disease—Doxorubicin—bone cancer	0.000321	0.00189	CcSEcCtD
Furosemide—Angiopathy—Methotrexate—bone cancer	0.000319	0.00188	CcSEcCtD
Furosemide—Immune system disorder—Methotrexate—bone cancer	0.000318	0.00187	CcSEcCtD
Furosemide—Visual impairment—Epirubicin—bone cancer	0.000317	0.00187	CcSEcCtD
Furosemide—Agranulocytosis—Doxorubicin—bone cancer	0.000317	0.00187	CcSEcCtD
Furosemide—Diarrhoea—Cisplatin—bone cancer	0.000312	0.00184	CcSEcCtD
Furosemide—Erythema multiforme—Epirubicin—bone cancer	0.000311	0.00184	CcSEcCtD
Furosemide—Eye disorder—Epirubicin—bone cancer	0.000308	0.00181	CcSEcCtD
Furosemide—Tinnitus—Epirubicin—bone cancer	0.000307	0.00181	CcSEcCtD
Furosemide—Malnutrition—Methotrexate—bone cancer	0.000306	0.00181	CcSEcCtD
Furosemide—Erythema—Methotrexate—bone cancer	0.000306	0.00181	CcSEcCtD
Furosemide—Urinary tract disorder—Doxorubicin—bone cancer	0.000301	0.00177	CcSEcCtD
Furosemide—Dysgeusia—Methotrexate—bone cancer	0.0003	0.00177	CcSEcCtD
Furosemide—Angiopathy—Epirubicin—bone cancer	0.000299	0.00176	CcSEcCtD
Furosemide—Urethral disorder—Doxorubicin—bone cancer	0.000299	0.00176	CcSEcCtD
Furosemide—Immune system disorder—Epirubicin—bone cancer	0.000297	0.00175	CcSEcCtD
Furosemide—Arrhythmia—Epirubicin—bone cancer	0.000294	0.00173	CcSEcCtD
Furosemide—Visual impairment—Doxorubicin—bone cancer	0.000294	0.00173	CcSEcCtD
Furosemide—Vomiting—Cisplatin—bone cancer	0.00029	0.00171	CcSEcCtD
Furosemide—Vision blurred—Methotrexate—bone cancer	0.000289	0.0017	CcSEcCtD
Furosemide—Erythema multiforme—Doxorubicin—bone cancer	0.000288	0.0017	CcSEcCtD
Furosemide—Rash—Cisplatin—bone cancer	0.000287	0.00169	CcSEcCtD
Furosemide—Dermatitis—Cisplatin—bone cancer	0.000287	0.00169	CcSEcCtD
Furosemide—Malnutrition—Epirubicin—bone cancer	0.000287	0.00169	CcSEcCtD
Furosemide—Erythema—Epirubicin—bone cancer	0.000287	0.00169	CcSEcCtD
Furosemide—Eye disorder—Doxorubicin—bone cancer	0.000285	0.00168	CcSEcCtD
Furosemide—Tinnitus—Doxorubicin—bone cancer	0.000284	0.00167	CcSEcCtD
Furosemide—Anaemia—Methotrexate—bone cancer	0.000283	0.00167	CcSEcCtD
Furosemide—Flatulence—Epirubicin—bone cancer	0.000282	0.00167	CcSEcCtD
Furosemide—Dysgeusia—Epirubicin—bone cancer	0.000281	0.00165	CcSEcCtD
Furosemide—Angiopathy—Doxorubicin—bone cancer	0.000276	0.00163	CcSEcCtD
Furosemide—Muscle spasms—Epirubicin—bone cancer	0.000276	0.00162	CcSEcCtD
Furosemide—Immune system disorder—Doxorubicin—bone cancer	0.000275	0.00162	CcSEcCtD
Furosemide—Vertigo—Methotrexate—bone cancer	0.000275	0.00162	CcSEcCtD
Furosemide—Leukopenia—Methotrexate—bone cancer	0.000274	0.00162	CcSEcCtD
Furosemide—Arrhythmia—Doxorubicin—bone cancer	0.000272	0.0016	CcSEcCtD
Furosemide—Nausea—Cisplatin—bone cancer	0.000271	0.0016	CcSEcCtD
Furosemide—Vision blurred—Epirubicin—bone cancer	0.00027	0.00159	CcSEcCtD
Furosemide—Erythema—Doxorubicin—bone cancer	0.000265	0.00156	CcSEcCtD
Furosemide—Malnutrition—Doxorubicin—bone cancer	0.000265	0.00156	CcSEcCtD
Furosemide—Anaemia—Epirubicin—bone cancer	0.000265	0.00156	CcSEcCtD
Furosemide—Agitation—Epirubicin—bone cancer	0.000263	0.00155	CcSEcCtD
Furosemide—Flatulence—Doxorubicin—bone cancer	0.000261	0.00154	CcSEcCtD
Furosemide—Dysgeusia—Doxorubicin—bone cancer	0.00026	0.00153	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000259	0.00153	CcSEcCtD
Furosemide—Vertigo—Epirubicin—bone cancer	0.000257	0.00152	CcSEcCtD
Furosemide—Leukopenia—Epirubicin—bone cancer	0.000257	0.00151	CcSEcCtD
Furosemide—Muscle spasms—Doxorubicin—bone cancer	0.000255	0.0015	CcSEcCtD
Furosemide—Confusional state—Methotrexate—bone cancer	0.000252	0.00149	CcSEcCtD
Furosemide—Anaphylactic shock—Methotrexate—bone cancer	0.00025	0.00147	CcSEcCtD
Furosemide—Vision blurred—Doxorubicin—bone cancer	0.00025	0.00147	CcSEcCtD
Furosemide—Nervous system disorder—Methotrexate—bone cancer	0.000245	0.00145	CcSEcCtD
Furosemide—Anaemia—Doxorubicin—bone cancer	0.000245	0.00145	CcSEcCtD
Furosemide—Thrombocytopenia—Methotrexate—bone cancer	0.000245	0.00144	CcSEcCtD
Furosemide—Agitation—Doxorubicin—bone cancer	0.000244	0.00144	CcSEcCtD
Furosemide—Skin disorder—Methotrexate—bone cancer	0.000243	0.00143	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000242	0.00143	CcSEcCtD
Furosemide—Hyperhidrosis—Methotrexate—bone cancer	0.000242	0.00142	CcSEcCtD
Furosemide—Dry mouth—Epirubicin—bone cancer	0.000239	0.00141	CcSEcCtD
Furosemide—Vertigo—Doxorubicin—bone cancer	0.000238	0.0014	CcSEcCtD
Furosemide—Anorexia—Methotrexate—bone cancer	0.000238	0.0014	CcSEcCtD
Furosemide—Leukopenia—Doxorubicin—bone cancer	0.000237	0.0014	CcSEcCtD
Furosemide—Confusional state—Epirubicin—bone cancer	0.000236	0.00139	CcSEcCtD
Furosemide—Anaphylactic shock—Epirubicin—bone cancer	0.000234	0.00138	CcSEcCtD
Furosemide—Hypotension—Methotrexate—bone cancer	0.000234	0.00138	CcSEcCtD
Furosemide—Shock—Epirubicin—bone cancer	0.00023	0.00136	CcSEcCtD
Furosemide—Nervous system disorder—Epirubicin—bone cancer	0.000229	0.00135	CcSEcCtD
Furosemide—Thrombocytopenia—Epirubicin—bone cancer	0.000229	0.00135	CcSEcCtD
Furosemide—Skin disorder—Epirubicin—bone cancer	0.000227	0.00134	CcSEcCtD
Furosemide—Hyperhidrosis—Epirubicin—bone cancer	0.000226	0.00133	CcSEcCtD
Furosemide—Paraesthesia—Methotrexate—bone cancer	0.000224	0.00132	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000224	0.00132	CcSEcCtD
Furosemide—Anorexia—Epirubicin—bone cancer	0.000223	0.00131	CcSEcCtD
Furosemide—Somnolence—Methotrexate—bone cancer	0.000222	0.00131	CcSEcCtD
Furosemide—Dry mouth—Doxorubicin—bone cancer	0.000221	0.0013	CcSEcCtD
Furosemide—Hypotension—Epirubicin—bone cancer	0.000219	0.00129	CcSEcCtD
Furosemide—Confusional state—Doxorubicin—bone cancer	0.000218	0.00129	CcSEcCtD
Furosemide—Decreased appetite—Methotrexate—bone cancer	0.000217	0.00128	CcSEcCtD
Furosemide—Anaphylactic shock—Doxorubicin—bone cancer	0.000216	0.00128	CcSEcCtD
Furosemide—Gastrointestinal disorder—Methotrexate—bone cancer	0.000216	0.00127	CcSEcCtD
Furosemide—Fatigue—Methotrexate—bone cancer	0.000215	0.00127	CcSEcCtD
Furosemide—Pain—Methotrexate—bone cancer	0.000214	0.00126	CcSEcCtD
Furosemide—Shock—Doxorubicin—bone cancer	0.000213	0.00126	CcSEcCtD
Furosemide—Nervous system disorder—Doxorubicin—bone cancer	0.000212	0.00125	CcSEcCtD
Furosemide—Thrombocytopenia—Doxorubicin—bone cancer	0.000212	0.00125	CcSEcCtD
Furosemide—Skin disorder—Doxorubicin—bone cancer	0.00021	0.00124	CcSEcCtD
Furosemide—Paraesthesia—Epirubicin—bone cancer	0.00021	0.00124	CcSEcCtD
Furosemide—Hyperhidrosis—Doxorubicin—bone cancer	0.000209	0.00123	CcSEcCtD
Furosemide—Somnolence—Epirubicin—bone cancer	0.000208	0.00123	CcSEcCtD
Furosemide—Anorexia—Doxorubicin—bone cancer	0.000206	0.00122	CcSEcCtD
Furosemide—Feeling abnormal—Methotrexate—bone cancer	0.000206	0.00121	CcSEcCtD
Furosemide—Gastrointestinal pain—Methotrexate—bone cancer	0.000204	0.0012	CcSEcCtD
Furosemide—Decreased appetite—Epirubicin—bone cancer	0.000203	0.0012	CcSEcCtD
Furosemide—Hypotension—Doxorubicin—bone cancer	0.000202	0.00119	CcSEcCtD
Furosemide—Gastrointestinal disorder—Epirubicin—bone cancer	0.000202	0.00119	CcSEcCtD
Furosemide—Fatigue—Epirubicin—bone cancer	0.000202	0.00119	CcSEcCtD
Furosemide—Pain—Epirubicin—bone cancer	0.0002	0.00118	CcSEcCtD
Furosemide—Constipation—Epirubicin—bone cancer	0.0002	0.00118	CcSEcCtD
Furosemide—Urticaria—Methotrexate—bone cancer	0.000199	0.00117	CcSEcCtD
Furosemide—Body temperature increased—Methotrexate—bone cancer	0.000198	0.00116	CcSEcCtD
Furosemide—Abdominal pain—Methotrexate—bone cancer	0.000198	0.00116	CcSEcCtD
Furosemide—Paraesthesia—Doxorubicin—bone cancer	0.000194	0.00115	CcSEcCtD
Furosemide—Feeling abnormal—Epirubicin—bone cancer	0.000193	0.00114	CcSEcCtD
Furosemide—Somnolence—Doxorubicin—bone cancer	0.000192	0.00113	CcSEcCtD
Furosemide—Gastrointestinal pain—Epirubicin—bone cancer	0.000191	0.00113	CcSEcCtD
Furosemide—Decreased appetite—Doxorubicin—bone cancer	0.000188	0.00111	CcSEcCtD
Furosemide—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000187	0.0011	CcSEcCtD
Furosemide—Fatigue—Doxorubicin—bone cancer	0.000187	0.0011	CcSEcCtD
Furosemide—Urticaria—Epirubicin—bone cancer	0.000186	0.0011	CcSEcCtD
Furosemide—Pain—Doxorubicin—bone cancer	0.000185	0.00109	CcSEcCtD
Furosemide—Constipation—Doxorubicin—bone cancer	0.000185	0.00109	CcSEcCtD
Furosemide—Body temperature increased—Epirubicin—bone cancer	0.000185	0.00109	CcSEcCtD
Furosemide—Abdominal pain—Epirubicin—bone cancer	0.000185	0.00109	CcSEcCtD
Furosemide—Hypersensitivity—Methotrexate—bone cancer	0.000184	0.00109	CcSEcCtD
Furosemide—Asthenia—Methotrexate—bone cancer	0.000179	0.00106	CcSEcCtD
Furosemide—Feeling abnormal—Doxorubicin—bone cancer	0.000178	0.00105	CcSEcCtD
Furosemide—Gastrointestinal pain—Doxorubicin—bone cancer	0.000177	0.00104	CcSEcCtD
Furosemide—Pruritus—Methotrexate—bone cancer	0.000177	0.00104	CcSEcCtD
Furosemide—Hypersensitivity—Epirubicin—bone cancer	0.000172	0.00102	CcSEcCtD
Furosemide—Urticaria—Doxorubicin—bone cancer	0.000172	0.00101	CcSEcCtD
Furosemide—Body temperature increased—Doxorubicin—bone cancer	0.000171	0.00101	CcSEcCtD
Furosemide—Abdominal pain—Doxorubicin—bone cancer	0.000171	0.00101	CcSEcCtD
Furosemide—Diarrhoea—Methotrexate—bone cancer	0.000171	0.00101	CcSEcCtD
Furosemide—Asthenia—Epirubicin—bone cancer	0.000168	0.000989	CcSEcCtD
Furosemide—Pruritus—Epirubicin—bone cancer	0.000165	0.000976	CcSEcCtD
Furosemide—Dizziness—Methotrexate—bone cancer	0.000165	0.000974	CcSEcCtD
Furosemide—Diarrhoea—Epirubicin—bone cancer	0.00016	0.000944	CcSEcCtD
Furosemide—Hypersensitivity—Doxorubicin—bone cancer	0.000159	0.00094	CcSEcCtD
Furosemide—Vomiting—Methotrexate—bone cancer	0.000159	0.000937	CcSEcCtD
Furosemide—Rash—Methotrexate—bone cancer	0.000158	0.000929	CcSEcCtD
Furosemide—Dermatitis—Methotrexate—bone cancer	0.000157	0.000928	CcSEcCtD
Furosemide—Headache—Methotrexate—bone cancer	0.000157	0.000923	CcSEcCtD
Furosemide—Asthenia—Doxorubicin—bone cancer	0.000155	0.000915	CcSEcCtD
Furosemide—Dizziness—Epirubicin—bone cancer	0.000155	0.000912	CcSEcCtD
Furosemide—Pruritus—Doxorubicin—bone cancer	0.000153	0.000903	CcSEcCtD
Furosemide—Vomiting—Epirubicin—bone cancer	0.000149	0.000877	CcSEcCtD
Furosemide—Nausea—Methotrexate—bone cancer	0.000148	0.000875	CcSEcCtD
Furosemide—Diarrhoea—Doxorubicin—bone cancer	0.000148	0.000873	CcSEcCtD
Furosemide—Rash—Epirubicin—bone cancer	0.000147	0.000869	CcSEcCtD
Furosemide—Dermatitis—Epirubicin—bone cancer	0.000147	0.000869	CcSEcCtD
Furosemide—Headache—Epirubicin—bone cancer	0.000147	0.000864	CcSEcCtD
Furosemide—Dizziness—Doxorubicin—bone cancer	0.000143	0.000844	CcSEcCtD
Furosemide—Nausea—Epirubicin—bone cancer	0.000139	0.000819	CcSEcCtD
Furosemide—Vomiting—Doxorubicin—bone cancer	0.000138	0.000811	CcSEcCtD
Furosemide—Rash—Doxorubicin—bone cancer	0.000136	0.000805	CcSEcCtD
Furosemide—Dermatitis—Doxorubicin—bone cancer	0.000136	0.000804	CcSEcCtD
Furosemide—Headache—Doxorubicin—bone cancer	0.000136	0.000799	CcSEcCtD
Furosemide—Nausea—Doxorubicin—bone cancer	0.000129	0.000758	CcSEcCtD
